Related Experiment Video
Updated: Jan 29, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Aortic dilatation in complex congenital heart disease
1Department of Cardiology, Cardiovascular Center, St Luke's International Hospital, Tokyo, Japan.
Insights
Aortic abnormalities like dilatation and dissection are common in congenital heart diseases (CHD) and bicuspid aortic valves. Medical treatments show limited success, often requiring surgical intervention for aortopathy.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Congenital Heart Disease
Background:
- Bicuspid aortic valve and coarctation of the aorta (COA) are linked to ascending aorta dilatation.
- Complex congenital heart diseases (CHD) like TGA, TOF, HLHS, and Fontan procedures are associated with aortic root issues, including fatal dissections.
- Aortic medial degeneration is prevalent in these conditions, leading to progressive aortic root dilatation even after repair.
Purpose of the Study:
- To review the pathophysiology and management of aortopathy in patients with congenital heart disease and bicuspid aortic valves.
- To highlight the increased risk of aortic dilatation, aneurysm, and dissection in these patient populations.
- To discuss current medical and surgical treatment strategies for aortopathy.
Main Methods:
- Literature review of studies on aortopathy in congenital heart disease, bicuspid aortic valve, and Marfan syndrome.
- Analysis of the prevalence and progression of aortic medial degeneration.
- Evaluation of medical therapies (beta-blockers, ARBs, Ca-antagonists) and surgical interventions (Bentall operation, valve-sparing procedures).
Main Results:
- Aortic medial degeneration is a key factor in ascending aorta dilatation and dissection in CHD and bicuspid aortic valve.
- Medial degeneration is more severe in Marfan syndrome, bicuspid aortic valve, and COA compared to other CHDs.
- Medical treatments have limited efficacy in slowing aortic dilatation, except possibly in Marfan syndrome.
Conclusions:
- Aortopathy, characterized by aortic abnormalities, is a significant concern in CHD and bicuspid aortic valve patients.
- Surgical repair, including valve-sparing options, is often necessary to manage aortic root dilatation and prevent cardiovascular events.
- Further research is needed to identify effective medical therapies to slow the progression of aortopathy.
Abstract:
A bicuspid aortic valve and/or coarctation of the aorta (COA) are often associated with dilatation of the ascending aorta and para-coarctation. Congenital heart diseases (CHD), such as truncus arteriosus, transposition of the great arteries (TGA), tetralogy of Fallot (TOF), hypoplastic left heart syndrome (HLHS), single ventricle with pulmonary stenosis/atresia and the Fontan procedure, are also associated with aortic root dilatation, aneurysm and rarely, dissection, which can be fatal and require aortic valve and root surgery. A significant subset of adults with complex CHD exhibit progressive dilatation of the aortic root even after repair due to aortic medial degeneration. Medial degeneration in the ascending aorta is prevalent among the above CHD. In Marfan syndrome, bicuspid aortic valve and COA, medial degeneration is more extensive and severe than in another complex CHD. Accordingly, the incidence of ascending aortic dilatation, dissection and rupture is higher in the former. This aortic medial degeneration in CHD may either be intrinsic or secondary to the increased volume overload of the aortic root due to right-to-left shunting, or a combination of both. The association of aortic pathophysiological abnormalities, aortic dilatation and aorto-ventricular interaction is clinically referred to as "aortopathy". The major purpose of medical treatment for aortopathy is to reduce the structural changes within the aortic wall and slow down the progression of aortic dilatation to reduce the risk of cardiovascular events. Several medications have been studied, including β-blockers, angiotensin II type I (AT1) receptor blockers (ARBs) and Ca-antagonists. However, the results, except for Marfan syndrome, are limited. In aortopathy, concomitant aortic valve and aortic root repair/replacement is required. The Bentall operation comprises root replacement with an aortic tube graft and mechanical valve, and has been widely applied. On the other hand, valve-sparing operations have been developed in order to preserve the aortic valve.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Anatomy of the Heart
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management

